Showing results (111-120 of 147) with videos related to
Sort By:
Pageof 15
Rheumatology (Oxford, England)|February 12, 2021
A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosisSung Hae Chang, Jae Bum Jun, Yun Jong Lee, et al.Arthritis Research & Therapy|July 19, 2024
Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort studyYeo-Jin Song, Hyoungyoung Kim, Soo-Kyung Cho, et al.BMC Musculoskeletal Disorders|February 26, 2016
The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritisJoo-Hyun Lee, Yoon-Kyoung Sung, Chan-Bum Choi, et al.RMD Open|December 29, 2022
<i>MUC5B</i> promoter variant rs35705950, rare but significant susceptibility locus in rheumatoid arthritis-interstitial lung disease with usual interstitial pneumonia in Asian populationsYoung Bin Joo, Soo Min Ahn, So-Young Bang, et al.BMC Medical Genomics|July 4, 2013
Integrative analysis of congenital muscular torticollis: from gene expression to clinical significanceShin-Young Yim, Dukyong Yoon, Myong Chul Park, et al.Journal of Korean Medical Science|March 3, 2015
Seasonality of gout in Korea: a multicenter studyHyo Jin Choi, Chan Hee Lee, Joo Hyun Lee, et al.Korean Circulation Journal|December 2, 2009
Beneficial and adverse effects of bosentan treatment in korean patients with pulmonary artery hypertensionDae-Won Sohn, Hyung-Kwan Kim, Myung-A Kim, et al.The Korean Journal of Internal Medicine|December 14, 2017
Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritisSoo-Kyoung Cho, Dam Kim, Soyoung Won, et al.International Journal of Rheumatic Diseases|November 7, 2018
Impact of EUSTAR standardized training on accuracy of modified Rodnan skin score in patients with systemic sclerosisJun Won Park, Ga Young Ahn, Ji-Won Kim, et al.Annals of the Rheumatic Diseases|February 1, 2025
Genetic burden of lupus increases the risk of transition from normal to preclinical autoimmune conditions via antinuclear antibody developmentSehwan Chun, So-Young Bang, Ayeong Kwon, et al.Pageof 15